{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:59:07Z","timestamp":1792011547355,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijrobp.2022.06.078","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T09:22:09Z","timestamp":1656235329000},"page":"1022-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0661-4420","authenticated-orcid":false,"given":"Joshua P.","family":"Schiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley B.","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Laugeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Hatscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Hugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed N.","family":"Badiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.06.078_bib0001","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0002","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0003","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0004","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0006","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2006.09.7469","article-title":"Stereotactic body radiation therapy in multiple organ sites","volume":"25","author":"Timmerman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0007","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/j.ijrobp.2012.06.005","article-title":"Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies","volume":"84","author":"Bae","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0008","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00384-013-1717-6","article-title":"Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies","volume":"28","author":"Bae","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-7-126","article-title":"Stereotactic body radiation therapy for abdominal oligometastases: A biological and clinical review","volume":"7","author":"Almaghrabi","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0010","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aae7fd","article-title":"The radiobiological impact of motion tracking of liver, pancreas and kidney SBRT tumors in a MR-linac","volume":"63","author":"Al-Ward","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0011","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00432-021-03739-8","article-title":"Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases","volume":"147","author":"Cuccia","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semradonc.2019.02.007","article-title":"Adaptive radiotherapy for anatomical changes","volume":"29","author":"Sonke","year":"2019","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2022.06.078_bib0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","article-title":"Two-and-a-half-year clinical experience with the world\u2019s first magnetic resonance image guided radiation therapy system","volume":"2","author":"Fischer-Valuck","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2022.06.078_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semradonc.2019.02.004","article-title":"Practical Clinical Workflows for Online and Offline Adaptive Radiation Therapy","volume":"29","author":"Green","year":"2019","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2022.06.078_bib0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ijrobp.2022.06.078_bib0016","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2016.08.036","article-title":"Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages","volume":"96","author":"Henke","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2022.01.038","article-title":"SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes","volume":"168","author":"Regnery","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0018","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1002\/cam4.4139","article-title":"Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis","volume":"10","author":"Yoon","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/0284186X.2021.2012593","article-title":"Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac","volume":"61","author":"Daamen","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0020","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/mp.14757","article-title":"Technical note: An alternative approach to verify 6FFF beam dosimetry for Ethos and MR Linac without using a 3D water tank","volume":"48","author":"Hao","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0021","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acm2.13399","article-title":"Prospects for daily online adaptive radiotherapy via ethos for prostate cancer patients without nodal involvement using unedited CBCT auto-segmentation","volume":"22","author":"Moazzezi","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0022","doi-asserted-by":"crossref","first-page":"e13539","DOI":"10.1002\/acm2.13539","article-title":"Assessment of efficacy in automated plan generation for Varian Ethos intelligent optimization engine","volume":"23","author":"Pokharel","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","article-title":"Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer","volume":"125","author":"Bohoudi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2020.12.004","article-title":"Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region","volume":"17","author":"Sibolt","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13014-020-1480-0","article-title":"Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients","volume":"15","author":"K\u00f6nig","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0026","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1200\/JCO.2001.19.1.164","article-title":"Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I\/II trial","volume":"19","author":"Herfarth","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0027","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.prro.2014.09.006","article-title":"Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control","volume":"5","author":"Rwigema","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0028","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prro.2012.03.005","article-title":"Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer","volume":"3","author":"Furman","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semradonc.2015.11.009","article-title":"Small bowel dose tolerance for stereotactic body radiation therapy","volume":"26","author":"LaCouture","year":"2016","journal-title":"Sem Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.06.078_bib0030","article-title":"In silico single fraction stereotactic ablative radiation therapy for the treatment of thoracic and abdominal oligometastatic disease with online adaptive magnetic resonance guidance","volume":"6","author":"Lee","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijrobp.2022.06.078_bib0031","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2021.08.033","article-title":"Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer","volume":"112","author":"Henke","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622006393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622006393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:03:23Z","timestamp":1759745003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622006393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0360301622006393"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.078","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}